Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss Biomed S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-01-18
Share capital
8,032,700.00 PLN
Activity description

Instytut Biotechnologii Surowic I Szczepionek Biom is a Polish pharmaceutical and biotechnology company that produces biological medicines, specialized probiotics, rehydration solutions, and in vitro microbiological diagnostic products. They manufacture a variety of vaccines, including a unique vaccine against Pseudomonas aeruginosa, and ensure high-quality standards through GMP practices. The company collaborates with partners from dozens of countries, providing support for registration, promotion, and distribution of their products.

Registered address
Al.sosnowa 8, 30-224 Kraków, Poland
Website
Email
Phone
Electronic delivery address
AE:PL-22282-36577-EFDFJ-26

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$3,078,228

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 13 days late). All were audited by a statutory auditor.

  • 2025filed
  • 202403/07/2025
  • 202319/06/2024
  • 202230/06/2023
  • 202128/07/2022
  • 202025/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing1,615 / 24,548
Top 6.6%
City · Kraków195 / 16,145
Top 1.2%
Voivodeship · Małopolskie409 / 27,724
Top 1.5%
Country · Poland5,629 / 297,069
Top 1.9%

Results vs industry

Revenue
This companyUSD 40.63mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 19.80mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 15.45mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 262.25mMedianUSD 897.46kAverageUSD 31.52m

Offer

Certifications: GMP, HACCP, ISO 13485, ISO 22000

Websites

  • biomed.plStrona główna – Biomed
    WordPress 7.1Google Tag ManagerYoast SEOWPMLApache
  • blonicaitezec.info.plTężec i błonica. Strona w trakcie budowy
    Apache

Public procurement

102 tenders recorded as contractor: 57 national ($451,971) and 45 EU ($40,146,570).

SubjectAmount
Open tender PN/13PL/06/2026 for the supply of medicinal products and medical devices
$17,492
Open tender PN/13PL/06/2026 for the supply of medicinal products and medical devices
$2,898
Successive supply of medicines to the hospital pharmacy
$1,729

Trademarks

The company holds 5 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2023.

MarkNumberClassesStatusProtected until
ORSONUDI (word)Z.5939885Protected Nov 19, 2035
LANO GLOW (word)Z.5852703, 5Protected May 28, 2035
NUDICOL (word)Z.5765855Protected Nov 8, 2034
DENUDIN (word)Z.5765865Protected Nov 8, 2034
BRACELAN (word)Z.5616613, 5, 35Protected Oct 17, 2033
MarkProtected until
ORSONUDI (word)Nov 19, 2035
LANO GLOW (word)May 28, 2035
NUDICOL (word)Nov 8, 2034
DENUDIN (word)Nov 8, 2034
BRACELAN (word)Oct 17, 2033

Job offers

The company lists 1 job opening on its own careers page: biomed.pl/kariera.

Position
Pharmaceutical representative

Authorized Representatives

Anna Flis age 52 – President of the Management Board
Barbara Łukawska age 62 – Attorney-in-fact (joint)
Tomasz Betlej age 63 – Attorney-in-fact (joint)
Elżbieta Waga age 54 – Attorney-in-fact (joint)

Manner of representation

Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.

Supervisory board

Przemysław Andrzej Krupiński age 37 – Supervisory Board Member
Maria Janina Pytlik age 61 – Supervisory Board Member
Robert Mrzygłód age 66 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1997-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$711.4K
Buildings and premises
$2.3M

MSiG notices

27 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
May 20, 2026Shareholders' meeting convened
May 21, 2025Shareholders' meeting convened
May 16, 2024Shareholders' meeting convened
May 15, 2023Shareholders' meeting convened
Jun 24, 2022Shareholders' meeting convened

Public aid

6 public aid cases recorded, with a total value of $3,257,419.

PurposeGross amount
Regional investment aid
$2.5M
Training aid
$2,904
Aid for research and development projects: experimental development
$518K

European Funds

ProjectEU co-financing
Automation and digitisation of the manufacturing process for critical vaccines DTP, Clodivac, Tetana, DT, D, d and TyT to strengthen the resilience of the EU supply chain
$2.5M

Regulatory authorisations

AuthorityTypeStatus
Integrated permit Active

Competitors

Name
Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.
Medicaline sp. z o.o.
Phytopharm Klęka S.A.
Biogen Poland sp. z o.o.
Natubay sp. z o.o.
Zakłady Farmaceutyczne Colfarm S.A.
Exim Pharma sp. z o.o.
Bio-Gen sp. z o.o.
Reig Jofre sp. z o.o.
Synthaverse S.A.

Change history

DateEvent
2012-11-13Share capital reduction
2009-12-23Name change
2005-07-21Name change
2004-11-09Share capital increase
2003-08-19Name change

FAQ

Last updated: 2026-03-20